Cerebral Oxygen Difference Monitoring for Needle-Free Hypoglycemia Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current continuous glucose monitoring devices for nocturnal hypoglycemia detection in young T1DM patients are invasive, costly, prone to false alarms, and require frequent recalibration, while non-invasive methods have remained elusive for over 35 years.
Innovation Solution
Non-intrusive detection of severe hypoglycemia onset by measuring cerebral arteriovenous oxygen difference using existing devices to monitor brain oxygen levels, enabling real-time detection without needles and integration with mobile devices for data analysis and alerts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If needle sensors are used for continuous glucose monitoring, then glucose levels can be monitored continuously, but the device becomes invasive and prone to false alarms
Solution Approach 1:
The patent replaces the mechanical needle-based sensor system with an optical imaging system using MRI technology. Instead of physically inserting sensors into tissue to measure glucose, the system uses magnetic resonance imaging to non-invasively detect glucose levels by measuring the magnetic resonance signal from glucose molecules in the brain, thereby eliminating invasiveness and associated false alarms
Solution Approach 2:
The patent introduces an intermediary approach by using cerebral blood flow and oxygen consumption as indirect indicators of brain glucose metabolism. Rather than measuring glucose directly through invasive sensors, the system monitors changes in cerebral hemodynamics that correlate with glucose utilization, providing reliable monitoring without direct tissue contact
2Productivity
If needle sensors are used for continuous glucose monitoring, then real-time detection is possible, but frequent recalibration and replacement are required
Solution Approach 1:
The patent replaces the mechanical sensor system requiring physical insertion and removal with a non-invasive MRI-based imaging system. This substitution allows for continuous monitoring without the need for sensor replacement, as the MRI scanner can repeatedly image the brain through the skull without any contact with tissue, eliminating calibration and replacement time
Solution Approach 2:
The patent leverages the universality of MRI technology, which is already a established medical imaging modality used for various neurological conditions. By adapting this existing multi-functional device for glucose monitoring, the system avoids the need for specialized sensor hardware that would require maintenance, calibration, and replacement
3Measurement precision
If needle sensors are used for continuous glucose monitoring, then glucose levels can be measured, but the cost is high and patient comfort is reduced
Solution Approach 1:
The patent replaces the invasive mechanical sensor insertion with non-invasive MRI imaging. The MRI scanner externally detects glucose-related magnetic resonance signals from the brain through the skull, maintaining measurement precision while completely eliminating the discomfort, pain, and psychological distress associated with needle insertion and wearable sensor adherence
Solution Approach 2:
The patent uses MRI technology to create a non-invasive copy or proxy measurement of brain glucose metabolism. Instead of directly contacting and measuring glucose at the tissue level, the system captures magnetic resonance signals that reflect glucose utilization patterns in the brain, providing accurate information without physical intrusion
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables continuous, comfortable monitoring of nocturnal hypoglycemia without disrupting sleep, reducing the risk of false alarms and eliminating the need for invasive sensors, and providing timely intervention.
Implementation Method 1
Such a decrease can be directly measured by the cerebral arteriovenous oxygen difference in a completely non-intrusive, needle-free way
Data Source
AI summary
Method for non-intrusive, needle-free detection of severe hypoglycemia onset through assessment of the cerebral arteriovenous oxygen difference. The method primarily pertains to the treatment of high-risk younger patients with Type 1 Diabetes Mellitus (T1DM) experiencing nocturnal hypoglycemia in order to prevent so called “Death in Bed” syndrome-the sudden death of young diabetic patients without any history of long-term complications.